<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7824467/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Previously reported anti-inflammatory activity of the essential oils (EOs) from the species under study.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">EO/EO Components’ Anti-Inflammatory Activity</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Family/Species</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Reference</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <b>Apiaceae</b>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Foeniculum vulgare</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.04 mg/mL). Fenchone inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.02 mg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B37-plants-10-00050" ref-type="bibr">37</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (200 and 400 mg/kg) decreased the activity of mieloperoxidase (MPO) and the expression of TNF-α in the colon tissue previously submitted to acetic acid solution (acute colitis), and inhibited acetic acid-induced expression of p‑NF-kB p65 protein.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B38-plants-10-00050" ref-type="bibr">38</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <b>Lamiaceae</b>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Lavandula luisieri</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (50–200 mg/kg) inhibition of paw edema (31–83%) induced by carrageenan administered in male Wistar rats.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B39-plants-10-00050" ref-type="bibr">39</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (25 μg/mL) nitric oxide (NO) inhibition (75%) in IL-1β induced primary chondrocyte.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B40-plants-10-00050" ref-type="bibr">40</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO reduction of iNOS in human chondrocytes and intestinal cell line C2BBe1 (54.9 and 81.0%, respectively) and phosphorylated IkB-α (87.4% and 62.3%, respectively).</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B41-plants-10-00050" ref-type="bibr">41</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Origanum majorana</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (10 μg/mL) diminished the TNF-α, IL‑1β, IL-6, IL-10 and COX-2 secretion and NFκB gene expression after activation of THP-1 cells by lipopolysaccharide or human ox – LDL. The activity was attributed to 
    <i>cis</i>-sabinene hydrate and terpinen‑4‑ol. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B42-plants-10-00050" ref-type="bibr">42</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Thymbra capitata</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.1 mg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B43-plants-10-00050" ref-type="bibr">43</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.2 mg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B44-plants-10-00050" ref-type="bibr">44</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Thymus mastichina</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.7 mg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B43-plants-10-00050" ref-type="bibr">43</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Thymus vulgaris</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.19 μg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B37-plants-10-00050" ref-type="bibr">37</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (0.5 μg/mL) inhibition (80%) of 5-lipoxygenase.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B45-plants-10-00050" ref-type="bibr">45</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.005 μg/mL). EO reduced the TNF-α, IL-1β, IL-8 secretion levels of THP-1 cells. 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B46-plants-10-00050" ref-type="bibr">46</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (400 mg/kg, after 6 h) reduced (50.4–58.4%) carrageenan-induced paw edema in mice.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B47-plants-10-00050" ref-type="bibr">47</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">Carvacrol (10 mg/ear) reduced ear edema. Carvacrol (10 mg/ear) inhibited the activity of myeloperoxidase (MPO) (43.8%). Carvacrol (0.3–90 μg/mL) reduced (20.07–52.23%) neutrophil migration in response to fMLP stimulation. EO (750 mg/kg) and carvacrol (100–400 mg/kg) exerted inhibited leukocyte migration to the injury site. Carvacrol (0.3‑90μg/mL) reduced LTB4 stimulation (19.8–61.1%).</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B48-plants-10-00050" ref-type="bibr">48</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO and carvacrol suppressed lipopolysaccharide-induced COX-2 mRNA and protein expression in human macrophage-like U937 cells.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B49-plants-10-00050" ref-type="bibr">49</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (moderate concentration) decreased the mRNA levels of IL-1β, IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and TNF-α, and lowered the amount of IL-1β and IL-6 proteins in animal models of colitis.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B50-plants-10-00050" ref-type="bibr">50</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO reduced production and gene expression of the pro-inflammatory mediators TNF‑α, IL-1B and IL-6 and increased the parameters on the anti-inflammatory IL-10 cytokine.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B51-plants-10-00050" ref-type="bibr">51</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (5000 ppm) decreased paw edema and ear swelling, inhibited the total mRNA IL‑1β expression in the mouse colon.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B52-plants-10-00050" ref-type="bibr">52</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Thymus zygis</i> subsp. 
    <i>zygis</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO thymol type inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 54 – 73 μL/L).EO linalool type inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 299 – 402 μL/L). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B53-plants-10-00050" ref-type="bibr">53</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO reduced production and gene expression of the pro-inflammatory mediators TNF‑α, IL-1B and IL-6 and increased the parameters on the anti-inflammatory IL-10 cytokine.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B51-plants-10-00050" ref-type="bibr">51</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <b>Myrtaceae</b>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <i>Eucalyptus globulus</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO inhibition of 5-lipoxygenase (IC 
    <sub>50</sub> = 0.16 mg/mL). 
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B37-plants-10-00050" ref-type="bibr">37</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">subsp. 
    <i>maidenii</i>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (0.5μg/mL) inhibition (50%) of lipoxygenase.</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B45-plants-10-00050" ref-type="bibr">45</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1">EO (200 mg/kg) inhibited by 28.8% the inflammatory phase of wound healing (Whittle method).</td>
   <td align="center" valign="middle" rowspan="1" colspan="1">[ 
    <a rid="B54-plants-10-00050" ref-type="bibr">54</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" rowspan="1" colspan="1">
    <b>Pinaceae</b>
   </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
   <td align="center" valign="middle" rowspan="1" colspan="1"> </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
    <i>Pinus pinaster</i>
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EO (100 mg/kg dose) inhibition (30.3%) of paw edema in the Whittle method using carrageenan.</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B55-plants-10-00050" ref-type="bibr">55</a>] 
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>EO: Essential oil. IC 
    <sub>50</sub>: Half-maximal inhibitory concentration. LDL: Low-density lipoprotein. COX‑2: Ciclo‑oxigenase-2. 
   </p>
  </p>
 </tfoot>
</table>
